Takeda Pharmaceutical proposes $62bn acquisition of Shire to expand rare disease capabilities

Takeda Pharmaceutical, a major Japanese pharmaceutical company, has made a $62 billion offer to acquire Shire, an Ireland-based leader in rare disease treatments. This proposal, ... Read More